2023 ANNUAL REPORT
Equity at the heart
of medical innovation
If there is a single highlight to look back on from 2023, it is the phenomenal power of partnership – the highlight of every one of our 20 years.
Foreword
2023 marked 20 years since our founding partners established DNDi, initiating an experiment in innovation and collaborative, not-for-profit pharmaceutical R&D centred on the needs of neglected patients. Throughout the year, we were grateful for the many opportunities to join with partners – in Latin America, East and West Africa, South and South-East Asia, Japan, North America, and Europe – to celebrate our collective successes in putting equity at the heart of medical innovation.
We also seized upon our anniversary milestone to look ahead. While the future may increasingly be defined by the climate crisis, geopolitical uncertainty, and the inevitability of new pandemics, it will also be shaped by the tremendous potential for scientific progress and medical innovation that transforms lives and livelihoods.
2023 in numbers
in our R&D portfolio, and an additional 14 projects in the treatment access phase
in 8 disease areas, including 16 trials testing new chemical entities
enrolled in active DNDi clinical studies
*Staff in full-time equivalents (FTEs)
represented among DNDi employees on 5 continents
DNDi WORLDWIDE
DNDi WORLDWIDE
Clinical sites
- Sleeping sickness
- Leishmaniasis
- Chagas disease
- Filaria: River blindness
- Mycetoma
- HIV
- Hepatitis C
- COVID-19
- R&D AND ACCESS PARTNERS
- DNDi OFFICES
- FOUNDING PARTNERS
- COUNTRIES WITH DNDi ACTIVITIES
RESEARCH & DEVELOPMENT PORTFOLIO
R&D PORTFOLIO
Acting as a ‘conductor of a virtual orchestra’, we collaborate with research partners around the world at all stages of the R&D process.
Our R&D portfolio includes 9 disease areas and 45 projects, 20 of which are focused on identifying or developing new chemical entities.
A WORD OF THANKS
DNDi has delivered 13 new treatments for six neglected diseases since 2003.
Photo credits: Brent Stirton/Getty Images for DNDi, Matt Bouch-DNDi, Paul Kamau-DNDi, Fábio Nascimento-DNDi, Lameck Ododo-DNDi, Ariane Mawaffo-DNDi, Scholars-DNDi, Sydelle Willow Smith-DNDi, Ana Ferreira-DNDi, Brent Stirton/Getty Images, Karin Schermbrucker-DNDi, Kumerra Gemechu-DNDi, Abang Amirrul Hadi-DNDi, Lucas Tavares-DNDi
Stay connected
Get our latest news, personal stories, research articles, and job opportunities.